Oral Terbinafine for Refractory Tinea Pedis
For refractory tinea pedis after topical therapy failure, treat with oral terbinafine 250 mg once daily for 2-6 weeks, with the specific duration depending on the clinical subtype and response.
Treatment Duration by Clinical Subtype
The evidence supports different treatment durations based on the presentation:
Interdigital Type (Most Common)
- 2 weeks of terbinafine 250 mg daily is highly effective 1, 2
- Clinical trials demonstrate 86% mycological cure rates with just 2 weeks of therapy 1
- This shorter duration is sufficient for most interdigital cases
Moccasin/Plantar Type (Hyperkeratotic)
- 4-6 weeks of terbinafine 250 mg daily is recommended 3
- This more extensive form requires longer treatment due to thicker stratum corneum involvement
- Studies show 75-88% response rates with 6-week courses 3
Intermittent Dosing Alternative
For patients with compliance concerns or cost considerations, 7-day courses of terbinafine 250 mg daily can be repeated based on clinical response 4, 5:
- Assess at 4-week intervals
- Repeat 7-day course if mycological or clinical cure not achieved
- Plantar type typically requires 1-2 cycles (65.9% cured with 1 cycle, additional 34.1% with 2 cycles) 4
- Interdigital type usually requires only 1 cycle (79.1% cure rate) 4
Key Clinical Considerations
Why Terbinafine Works for Short Courses
The fungicidal (not just fungistatic) activity of terbinafine against dermatophytes allows these abbreviated treatment durations 6. Additionally, terbinafine creates a drug reservoir in the stratum corneum that persists for up to 13 days after application, maintaining therapeutic levels even after treatment cessation 6.
Monitoring Requirements
Before initiating oral terbinafine 7:
- Obtain baseline serum transaminases (ALT/AST) - mandatory per FDA labeling
- Baseline complete blood count recommended
- Confirm diagnosis with KOH preparation and/or fungal culture
Important Safety Warnings
Discontinue terbinafine immediately if patient develops 7:
- Hepatotoxicity symptoms (nausea, anorexia, jaundice, right upper quadrant pain, dark urine)
- Taste or smell disturbances (can be permanent)
- Severe skin reactions (Stevens-Johnson syndrome, TEN, DRESS)
- Depressive symptoms
- Neutropenia (if count ≤1,000 cells/mm³)
Common Pitfalls to Avoid
Do not confuse tinea pedis with onychomycosis treatment durations. The guidelines you may encounter for 6-12 weeks of terbinafine apply to nail infections 8, not skin infections. Tinea pedis requires substantially shorter courses.
Do not automatically prescribe 12 weeks of therapy - this is excessive for isolated tinea pedis and increases unnecessary drug exposure and cost. The evidence clearly supports 2-6 week courses for skin infections 1, 2, 3.
Ensure concomitant onychomycosis is not present - if nail involvement exists, longer treatment (12 weeks for toenails, 6 weeks for fingernails) is required 8, 7.
Expected Outcomes and Relapse
- Mycological cure rates: 86-94% depending on subtype 4, 5, 1
- Annual relapse rates: approximately 10% per year over 3 years 4, 5
- Most relapses likely represent reinfection rather than treatment failure 4
- Clinical improvement continues after treatment cessation due to the reservoir effect 6
Superiority Over Alternatives
Terbinafine demonstrates superior efficacy compared to griseofulvin (RR 2.26,95% CI 1.49-3.44) 9 and achieves significantly higher cure rates than itraconazole at comparable durations (86.3% vs 54.5% mycological cure at 8 weeks with 2-week treatment) 2.